Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a Phase 3b, randomized, double-blind, placebo-controlled trial supplemental material and plain language summary
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://data.mendeley.com/datasets/h4s7y7fshf
下载链接
链接失效反馈官方服务：
资源简介：
This is the supplemental material and plain language summary for the manuscript titled, "Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a Phase 3b, randomized, double-blind, placebo-controlled trial" by Sofen H. et al., 2024.
创建时间：
2024-12-17
